Literature DB >> 32800436

Outcomes and Risk Factors of Extended Trochanteric Osteotomy in Aseptic Revision Total Hip Arthroplasty: A Systematic Review.

Michael-Alexander Malahias1, Ioannis Gkiatas1, Nicolas A Selemon1, Roberto De Filippis1, Alex Gu1, Alex Greenberg1, Peter K Sculco1.   

Abstract

BACKGROUND: Although extended trochanteric osteotomy (ETO) is an effective technique for femoral stem removal and for the concomitant management of proximal femoral deformities, complications including persistent pain, trochanteric nonunion, and painful hardware can occur.
METHODS: The US National Library of Medicine (PubMed/MEDLINE) and the Cochrane Database of Systematic Reviews were queried for publications utilizing the following keywords: "extended" AND "trochanteric" AND "osteotomy."
RESULTS: Nineteen articles were included in the present study with 1478 ETOs. The mean overall union rate of the ETO was 93.1% (1377 of 1478 cases), while the overall rate of radiographic femoral stem subsidence >5 mm was 7.1% (25 of 350 cases). ETO union rates and femoral stem subsidence rates were similar between patients with periprosthetic fractures treated with total hip arthroplasty (THA) revision and ETO and patients treated with THA revision and ETO for reasons other than fractures. There was limited evidence that prior femoral cementation and older age might negatively influence ETO union rates.
CONCLUSION: There was moderate quality evidence to show that the use of ETO in aseptic patients undergoing single-stage revision THA is safe and effective, with a 7% rate of ETO nonunion and subsidence >5 mm in 7%. ETO can be safely used in cases with periprosthetic fractures in which stem fixation is jeopardized and a reimplantation is required. A well-conducted ETO should be preferred in selective THA revision cases to prevent intraoperative femoral fractures which are associated with deteriorated clinical outcomes. The use of trochanteric plate with cables should be considered as the first choice for ETO fixation.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aseptic; extended trochanteric osteotomy; hip; revision; total hip arthroplasty

Mesh:

Year:  2020        PMID: 32800436     DOI: 10.1016/j.arth.2020.07.034

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  6 in total

1.  Greater trochanter fixed with a claw plate and cable system in complex primary and revision total hip arthroplasty: long-term follow-up.

Authors:  Jing Tang; Tiemure Wu; Hongyi Shao; Yixin Zhou
Journal:  Int Orthop       Date:  2022-08-23       Impact factor: 3.479

2.  Aseptic Revision of Total Hip Arthroplasty With a Single Modular Femoral Stem and a Modified Extended Trochanteric Osteotomy-Treatment Assessment With the Forgotten Joint Score-12.

Authors:  Anna-Katharina Calek; Thomas Schöfl; Vilijam Zdravkovic; Pia Zurmühle; Andreas Ladurner
Journal:  Arthroplast Today       Date:  2022-05-18

3.  Extended trochanteric osteotomy (ETO) and fluted tapered modular stems in revision hip arthroplasty. Does ETO integrity or consolidation, really matter?

Authors:  Germán Garabano; Alan Maximiliano Gessara; Cesar Angel Pesciallo; Leonel Perez Alamino; Hernán Del Sel
Journal:  J Orthop       Date:  2021-02-09

4.  Extended trochanteric osteotomy in revision hip arthroplasty: a case series study and systematic literature review.

Authors:  Khalid Hamad; Sujith Konan
Journal:  Arthroplasty       Date:  2022-04-03

5.  The Relationship Between Arthroplasty Surgeons' Experience Level and Optimal Cable Tensioning in the Fixation of Extended Trochanteric Osteotomy.

Authors:  Kerem Başarır; Mahmut Kalem; Ercan Şahin; Emre Anıl Özbek; Mustafa Onur Karaca; İbrahim Küçükkarapınar; Ergin Tönük
Journal:  Geriatr Orthop Surg Rehabil       Date:  2021-12-13

6.  Endofemoral Shooting Technique for Removing Well-fixed Cementless Stems.

Authors:  Kenichi Oe; Hirokazu Iida; Takashi Toyoda; Tomohisa Nakamura; Naofumi Okamoto; Takanori Saito
Journal:  Arthroplast Today       Date:  2022-08-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.